Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 26 articles: HTML format

Single Articles

January 2026
1. HIRODE G, Zangneh HF, Cerocchi O, Khalili K, et al
   Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial.
   Gastroenterology. 2026 Jan 20:S0016-5085(25)05993.
   PubMed     Abstract available
   
   
   November 2025
2. KIM NJ, Li M, Vutien P, Mecham B, et al
   Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening.
   Gastroenterology. 2025 Nov 14:S0016-5085(25)05906.
   PubMed     Abstract available
   
   
   
3. LOK AS, Ward JW, Chang MH, Cohen C, et al
   Hepatitis B Vaccination: A remarkable success story that must continue.
   Gastroenterology. 2025 Nov 13:S0016-5085(25)06482.
   PubMed    
   
   
   August 2025
4. KUSHNER T, Cohen SM, Ahn J, Wong RJ, et al
   AGA Clinical Practice Update on Management of Hepatitis Delta: Commentary.
   Gastroenterology. 2025 Aug 20:S0016-5085(25)05842.
   PubMed     Abstract available
   
   
   July 2025
5. JI Y, Le Bert N, Lai-Hung Wong G, Douglas MW, et al
   The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses.
   Gastroenterology. 2025;169:136-149.
   PubMed     Abstract available
   
   
   February 2025
6. ALI FS, Nguyen MH, Hernaez R, Huang DQ, et al
   AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.
   Gastroenterology. 2025;168:267-284.
   PubMed     Abstract available
   
   
   January 2025
7. KUMAR N, Chaudhary A
   Comments on "Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program".
   Gastroenterology. 2025 Jan 30:S0016-5085(25)00326.
   PubMed    
   
   
   November 2024
8. MEZZACAPPA C
   Gastro Digest: The Revised REACH-B Model Predicts Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
   Gastroenterology. 2024 Nov 30:S0016-5085(24)05756.
   PubMed    
   
   
   
9. ZHANG X, Klohn M, Ouwerkerk-Mahadevan S, Jagst M, et al
   A pan-genotypic hepatitis E virus replication inhibitor with high potency in a rat infection model.
   Gastroenterology. 2024 Nov 22:S0016-5085(24)05696.
   PubMed     Abstract available
   
   
   August 2024
10. PREMKUMAR M, Dhiman RK, Duseja A, Mehtani R, et al
    Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination program.
    Gastroenterology. 2024 Aug 22:S0016-5085(24)05359.
    PubMed     Abstract available
    
    
    
11. TRAN CS, Kersten J, Yan J, Breinig M, et al
    Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.
    Gastroenterology. 2024;167:522-537.
    PubMed     Abstract available
    
    
    July 2024
12. MEZZACAPPA C
    Gastro Digest: Integrated telemedicine to treat HCV through opioid treatment programs.
    Gastroenterology. 2024 Jul 16:S0016-5085(24)05213.
    PubMed    
    
    
    June 2024
13. LIAW YF
    Prediction of Clinical Relapse and HBsAg Loss After Cessation of Anti-HBV Therapy.
    Gastroenterology. 2024;166:1193.
    PubMed    
    
    
    May 2024
14. GOUTTENOIRE J, Neyts J
    A hepatitis E virus infection model in the Mongolian Gerbil: ready for antiviral and vaccine studies.
    Gastroenterology. 2024 May 23:S0016-5085(24)04938.
    PubMed    
    
    
    April 2024
15. GUTIERREZ SANCHEZ LH, Ibrahim SH
    Severe Acute Hepatitis of Unknown Etiology in Children: New Virus or Immune Dysregulation.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00481.
    PubMed    
    
    
    
16. LIU T, He Q, Yang X, Li Y, et al
    An Immunocompetent Mongolian Gerbil Model for Hepatitis E Virus Genotype 1 Infection.
    Gastroenterology. 2024 Apr 5:S0016-5085(24)00364.
    PubMed     Abstract available
    
    
    February 2024
17. TRIVEDI PJ, Hirschfield GM, Adams DH, Vierling JM, et al
    Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts.
    Gastroenterology. 2024 Feb 9:S0016-5085(24)00165.
    PubMed     Abstract available
    
    
    
18. HERMS Q, Fuster-Anglada C, Juanola A
    Pembrolizumab-induced Liver Injury: Beyond Immune-Mediated Hepatitis.
    Gastroenterology. 2024 Feb 4:S0016-5085(24)00133.
    PubMed    
    
    
    January 2024
19. PISATURO M, Alessio L, de Pascalis S, Messina V, et al
    A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy.
    Gastroenterology. 2024;166:191-193.
    PubMed    
    
    
    December 2023
20. LAI L, Rao C, Liu H
    An Unusual Cause of Ascites in a Patient with Hepatitis B.
    Gastroenterology. 2023 Dec 7:S0016-5085(23)05593.
    PubMed    
    
    
    November 2023
21. LENS S
    Successful HCV viral cure is not the end of the story.
    Gastroenterology. 2023 Nov 3:S0016-5085(23)05205.
    PubMed    
    
    
    October 2023
22. ZHENG D, Fang Z, Sun J
    Which is more clinically relevant: end-of-treatment or off-treatment predictors of hepatitis B relapse and surface antigen loss?
    Gastroenterology. 2023 Oct 25:S0016-5085(23)05196.
    PubMed    
    
    
    
23. LIM SG, Tan YC
    Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic Hepatitis B: Better But Not Enough.
    Gastroenterology. 2023 Oct 12:S0016-5085(23)05132.
    PubMed    
    
    
    
24. DARA L, Ghabril M, Phillips E, Kleiner D, et al
    A 68-year-old woman with unexplained liver enzyme elevation and active chronic hepatitis: Beware of drug induced autoimmune like hepatitis.
    Gastroenterology. 2023 Oct 3:S0016-5085(23)05078.
    PubMed    
    
    
    September 2023
25. SONNEVELD MJ, Chiu SM, Park JY, Brakenhoff SM, et al
    Hepatitis B Virus DNA and Hepatitis B e Antigen Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and Hepatitis B Antigen Loss in Hepatitis B e Antigen-Negative Patients Who Discontinued Antiviral Therapy.
    Gastroenterology. 2023 Sep 26:S0016-5085(23)05068.
    PubMed     Abstract available
    
    
    August 2023
26. CONGLY SE, Brahmania M, Coffin CS
    Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset.
    Gastroenterology. 2023 Aug 17:S0016-5085(23)04891.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum